Francis P Worden (Francis Worden)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Combination Therapy

Diffusion Weighted Imaging

Vascular Endothelial Growth Factor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Paul L Swiecicki, Emily Light Bellile, Aleksandar F Dragovic, Jonathan McHugh, Aaron M Udager, Michelle Lynn Mierzwa, Jennifer L Shah, Molly E Heft Neal, Andrew J Rosko, Kelly M Malloy, Keith A Casper, Steven Bennett Chinn, Andrew G Shuman, Chaz L Stucken, Douglas B Chepeha, Gregory T Wolf, Carol Rossier Bradford, Avraham Eisbruch, Mark E P Prince, Francis P Worden, Matthew E Spector
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Paul L Swiecicki, Emily Light Bellile, Aleksandar F Dragovic, Jonathan McHugh, Aaron M Udager, Michelle Lynn Mierzwa, Jennifer L Shah, Molly E Heft Neal, Andrew J Rosko, Kelly M Malloy, Keith A Casper, Steven Bennett Chinn, Andrew G Shuman, Chaz L Stucken, Douglas B Chepeha, Gregory T Wolf, Carol Rossier Bradford, Avraham Eisbruch, Mark E P Prince, Francis P Worden, Matthew E Spector
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Paul L Swiecicki, Emily Light Bellile, Aleksandar F Dragovic, Jonathan McHugh, Aaron M Udager, Michelle Lynn Mierzwa, Jennifer L Shah, Molly E Heft Neal, Andrew J Rosko, Kelly M Malloy, Keith A Casper, Steven Bennett Chinn, Andrew G Shuman, Chaz L Stucken, Douglas B Chepeha, Gregory T Wolf, Carol Rossier Bradford, Avraham Eisbruch, Mark E P Prince, Francis P Worden, Matthew E Spector
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Paul L Swiecicki, Emily Light Bellile, Aleksandar F Dragovic, Jonathan McHugh, Aaron M Udager, Michelle Lynn Mierzwa, Jennifer L Shah, Molly E Heft Neal, Andrew J Rosko, Kelly M Malloy, Keith A Casper, Steven Bennett Chinn, Andrew G Shuman, Chaz L Stucken, Douglas B Chepeha, Gregory T Wolf, Carol Rossier Bradford, Avraham Eisbruch, Mark E P Prince, Francis P Worden, Matthew E Spector
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis, Bhavana Konda, Ramona Dadu, Eric J Sherman, Shaylene McCue, Nathan R Foster, Yuri E Nikiforov, Ticiana Della Justina Farias, Paul J Norman, Lori J Wirth
Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Paul L Swiecicki, Emily Light Bellile, Aleksandar F Dragovic, Jonathan McHugh, Aaron M Udager, Michelle Lynn Mierzwa, Jennifer L Shah, Molly E Heft Neal, Andrew J Rosko, Kelly M Malloy, Keith A Casper, Steven Bennett Chinn, Andrew G Shuman, Chaz L Stucken, Douglas B Chepeha, Gregory T Wolf, Carol Rossier Bradford, Avraham Eisbruch, Mark E P Prince, Francis P Worden, Matthew E Spector
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis, Bhavana Konda, Ramona Dadu, Eric J Sherman, Shaylene McCue, Nathan R Foster, Yuri E Nikiforov, Ticiana Della Justina Farias, Paul J Norman, Lori J Wirth
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Paul L Swiecicki, Emily Light Bellile, Aleksandar F Dragovic, Jonathan McHugh, Aaron M Udager, Michelle Lynn Mierzwa, Jennifer L Shah, Molly E Heft Neal, Andrew J Rosko, Kelly M Malloy, Keith A Casper, Steven Bennett Chinn, Andrew G Shuman, Chaz L Stucken, Douglas B Chepeha, Gregory T Wolf, Carol Rossier Bradford, Avraham Eisbruch, Mark E P Prince, Francis P Worden, Matthew E Spector
Upfront neck dissection for treatment selection and improvement in quality of life as a novel treatment paradigm for deintensification in HPV+ OPSCC. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Francis P Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States. Endocrine 84 (2) (2023)
Francis P Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States. Endocrine (2023)
Glenn J Hanna, Myung-Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W Bowles, Deborah J Wong, Alan L Ho, Sung-Bae Kim, Francis P Worden, Tak Yun, Xianzhang Meng, Jan M Van Tornout, Maureen G Conlan, Hyunseok Kang
A Phase 2 Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Francis P Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States. Endocrine 84 (2) (2023)
Francis P Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States. Endocrine 84 (2) (2023)
Michelle Lynn Mierzwa, Madhava Aryal, Choonik Lee, Matthew J Schipper, Monica VanTil, Krystal Morales, Paul L Swiecicki, Keith A Casper, Kelly M Malloy, Matthew E Spector, Andrew G Shuman, Steven Bennett Chinn, Mark E P Prince, Chaz L Stucken, Andrew J Rosko, Theodore S Lawrence, John Chad Brenner, Benjamin S Rosen, Caitlin A Schonewolf, Jennifer L Shah, Avraham Eisbruch, Francis P Worden, Yue Cao
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Cherie Ann O Nathan, David Neil Hayes, Theodore Karrison, Olivier Harismendy, José M Flores, Tara Moore-Medlin, Everett E Vokes, Jorge Silvio Gutkind, Prakash Neupane, Glenn Mills, Zoukaa Sargi, Tanguy Seiwert, Juneko E Grilley Olson, Terry A Day, Maura L Gillison, James L Wade, Lawrence E Feldman, Gautam Jha, Mark Kozloff, Miriam O'Leary, Francis P Worden, Ezra E W Cohen
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)